Retinal Vein Occlusion Completed Phase 4 Trials for Ranibizumab (DB01270)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02140411Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.Treatment
NCT01580020Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVOTreatment
NCT01027481Ranibizumab in Patients With Branch Retinal Vein OcclusionTreatment
NCT01427751Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionTreatment